No greater incidence or worsening of cardiac valve regurgitation with somatostatin analog treatment of acromegaly

Abstract

The incidence of valve regurgitation did not change over 12 months of treatment with somatostatin analogs lanreotide and octreotide in patients with acromegaly

Keywords

• Acromegaly
• cardiac valve regurgitation
• treatment with somatostatin analogs
• lanreotide
• octreotide